Novartis eyes $39 billion majority stake in Alcon
In the wake of a slow-down in drug sales, Novartis has agreed to acquire fellow Swiss firm Nestle’s 77% stake in the USA’s Alcon, “the world leader in eye care”.
Read MoreAuthor: Kevin Grogan
Unfavourable environment forces AstraZeneca to cut Spain jobs
As part of its ongoing global restructuring, AstraZeneca has announced that 132 jobs are to be cut at its Spanish operations.
Read MoreGSK gets US approval for rotavirus jab Rotarix
As expected, US regulators have given the green light to GlaxoSmithKline’s rotavirus vaccine Rotarix, a move which will see the jab go up against Merck & Co’s rival product Rotateq.
Read MoreFDA panel rejects total ban on Amgen and J&J’s ESAs in cancer
A US regulatory advisory panel has recommended further restrictions on the use of Amgen and Johnson & Johnson’s anaemia drugs in cancer patients but the news could have been worse for the drugmakers.
Read MoreThailand figures reveal the benefit of compulsory licences
Activists in the USA who support Thailand’s decision to issue compulsory licences have been highlighting data which demonstrates that the policy is proving to be highly effective in getting HIV/AIDS drugs to more patients in the country.
Read More
